lopinavir has been researched along with Acute Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dong, CF; Feng, C; Gao, H; Li, JX; Li, YJ; Liu, L; Liu, YX; Wang, FX; Wang, LF; Wang, Y; Wu, WB; Xie, XJ; Yuan, J; Zeng, JH | 1 |
Cauda, R; Cingolani, A; Cipriani, MC; Fantoni, M; Gremese, E; Larosa, L; Liperoti, R; Montemurro, G; Murri, R; Pasciuto, G; Pirronti, T; Tummolo, AM | 1 |
Bellavita, G; Bonzi, L; Buoite Stella, A; Cecotti, L; D Acunto, L; Fabris, M; Furlanis, G; Manganotti, P; Pesavento, V; Sartori, A; Tommasini, V | 1 |
Agüero, F; Ambrosioni, J; Brunet, M; Caballero, M; de Lazzari, E; Gallart, T; Gatell, JM; Guardo, AC; López-Diéguez, M; Manzardo, C; Marcos, MÁ; Miró, JM; Mosquera, MM; Muñoz-Fernández, MÁ; Nicolás, D; Plana, M; Sued, O; Tuset, M | 1 |
Caumes, E; Duvivier, C; Ghosn, J; Katlama, C; Tubiana, R | 1 |
Ahlenstiel, G; Altfeld, M; Kaufmann, DE; Kupfer, B; Lichterfeld, M; Mui, SK; Rockstroh, JK; Spengler, U; Vogel, M; Voigt, E; Walker, B | 1 |
1 trial(s) available for lopinavir and Acute Disease
Article | Year |
---|---|
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclosporine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pilot Projects; Ritonavir; Young Adult | 2017 |
5 other study(ies) available for lopinavir and Acute Disease
Article | Year |
---|---|
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.
Topics: Acute Disease; Antiviral Agents; Bacteroides Infections; Betacoronavirus; Biomarkers; Candidiasis; Coronavirus Infections; COVID-19; Drug Combinations; Echocardiography; Fatal Outcome; Humans; Interleukin-6; Lopinavir; Male; Middle Aged; Myocarditis; Pandemics; Piperacillin, Tazobactam Drug Combination; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Stroke Volume; Tomography, X-Ray Computed; Troponin I | 2020 |
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Lopinavir; Male; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Respiratory Insufficiency; Ritonavir; SARS-CoV-2; Sulfonamides; Treatment Outcome | 2020 |
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.
Topics: Action Potentials; Acute Disease; Aged; Anti-Bacterial Agents; Biomarkers; Convalescence; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Guillain-Barre Syndrome; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Interleukin-6; Interleukin-8; Lopinavir; Male; Neural Conduction; Peripheral Nervous System; Prognosis; Respiratory Insufficiency; Ritonavir; SARS-CoV-2 | 2021 |
Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir.
Topics: Acute Disease; Adult; Anti-HIV Agents; Drug Eruptions; Exanthema; HIV Infections; Humans; Lopinavir; Male; Occupational Exposure; Pyrimidinones; Ritonavir; Skin Diseases, Vesiculobullous | 2005 |
Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Follow-Up Studies; Histocompatibility Testing; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Retrospective Studies; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine | 2006 |